Medication Counseling for Nonvalvular Atrial Fibrillation Patients with Poor Adherence to Direct Oral Anticoagulants: A Consideration from Motivational Interviews（SMAAP‒AF Study）-Reference-Cited by-同舟云学术

Medication Counseling for Nonvalvular Atrial Fibrillation Patients with Poor Adherence to Direct Oral Anticoagulants: A Consideration from Motivational Interviews（SMAAP‒AF Study）

Published:2024-05-31 Issue:3 Volume:55 Page:125-132
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics

Author:

UEDA Yoshiki¹,YOSHIYAMA Yuji¹,SAWADA Emi²,SHIGA Tsuyoshi²³,Investigators SMAAP-AF⁴

Affiliation:

1. Kitasato University School of Pharmacy, Tokyo, Japan

2. Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan

3. Department of Clinical Pharmacology and Therapeutics, Jikei University School of Medicine, Tokyo, Japan

4. Survey on Medication Adherence to Anticoagulant Drugs and Investigation of Improvement of Medication Adherence by an Educational Programin Nonvalvular Atrial Fibrillation

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Link

https://www.jstage.jst.go.jp/article/jscpt/55/3/55_125/_pdf

Reference10 articles.

1. 1) Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery （EACTS）: The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology （ESC） Developed with the special contribution of the European Heart Rhythm Association （EHRA） of the ESC. Eur Heart J. 2021; 42（5）: 373-498. doi:10.1093/eurheartj/ehaa612.

2. 2) 日本循環器学会/日本不整脈心電学会合同ガイドライン．2020 年改訂版　不整脈薬物治療ガイドライン．［https://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf （accessed 2023-11-12）］

3. 3) Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014 ; 383（9921）: 955-62. doi: 10.1016/S0140-6736（13）62343-0.

4. 4) Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, et al. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2020 ; 13（3）: e005969. doi: 10.1161/CIRCOUTCOMES.119.005969.

5. 5) Shiga T, Kimura T, Fukushima N, Yoshiyama Y, Iwade K, Mori F, et al; SMAAP-AF investigators. Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: baseline data from the SMAAP-AF trial. J Arrhythm. 2021; 37（3）: 616-25. doi: 10.1002/joa3.12532.